STUDIES ON CORONARY VASOSPASTICITY OF HETEROZYGOUS FAMILIAL HYPERCHOLESTE-ROLEMIA (FH) : Ischemic Heart Disease (V) : V : 48 Annual Scientific Meeting, Japanese Circulation Society
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本循環器学会の論文
- 1984-08-20
著者
-
Tatami Ryozo
Department Of Cardiology Maizuru Kyosai Hospital
-
Tatami Ryozo
Department Of Cardiology Maizuru Kyosai Hopital
-
Ishise Shozo
Department Of Cardiology Maizuru Kyosai Hospital
-
Ishise Shozo
Department Of Cardiology Maizuru Kyosai Hopital
-
Monji Tadasi
Department of Cardiology, Maizuru Kyosai Hopital
-
Monji Tadasi
Department Of Cardiology Maizuru Kyosai Hopital
関連論文
- STUDIES ON CORONARY VASOSPASTICITY OF HETEROZYGOUS FAMILIAL HYPERCHOLESTE-ROLEMIA (FH) : Ischemic Heart Disease (V) : V : 48 Annual Scientific Meeting, Japanese Circulation Society
- CLINICAL APPLICATION OF INTRACORONARY (I.C.) ERGONOVINE MALEATE (ERG) FOR DETECTING VASOSPASTIC ANGINA (VSA) : Ischemic Heart Disease (V) : V : 48 Annual Scientific Meeting, Japanese Circulation Society
- Evolution of Coronary Vascular Tone in Vasospastic Angina
- STUDY ON THE RELATION OF ACUTE MYOCARDIAL INFARCTION (AMI) ON THE DISTAL SITE OF THE CORONARY ARTERY WITH CORONARY SPASM : Ischemic Heart Disease : 53 Annual Scientific Meeting, Japanese Circulation Society
- -530- STUDIES ON THERAPEUTIC GUIDELINE FOR HYPERCHOLESTEROLEMIA BASED ON CORONARY ANGIOGPHIC FINDINGS
- -529- EFFECT OF HYPOLIPIDEMIC DRUGS ON CORONARY ATHEROSCLEROSIS ASSOCIATED WITH PRIMARY HYPERCHOLESTEROLEMIA
- -233- COMPARISON OF INTRACORONARY ECG WITH STANDARD 12-LEAD ECG IN PTCA : PTCA, CABG : FREE COMMUNICATIONS(II) : PROCEEDINGS OF THE 51th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- PLATELET FUNCTION, CORONARY SPASM AND ATHEROSCLEROTIC LESIONS : Coronary Spasm : PROCEEDINGS OF THE 50th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- LIPOPROTEIN COMPOSITION IN VASOSPASTIC ANGINA : Ischemic Heart Disease : PROCEEDINGS OF THE 50th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- Ten-year Follow-up of Familial Hypercholesterolemia Patients After Intensive Cholesterol-lowering Therapy